Prostate cancer screening in Europe

Affiliations

Comment

Martin Caicoya. Lancet. 2015.

. 2015 Apr 18;385(9977):1507.

doi: 10.1016/S0140-6736(15)60748-6.

¹ Regional Health Authority, Asturias 33006, Spain. Electronic address: martin.caicoyagomez-moran@asturias.org.

No abstract available

Comment in

Prostate cancer screening in Europe - Authors' reply.
Schröder F, Hugosson J, Carlsson S, Moss S, Roobol M, Auvinen A. Schröder F, et al. Lancet. 2015 Apr 18;385(9977):1507-8. doi: 10.1016/S0140-6736(15)60749-8. Lancet. 2015. PMID: 25933276 No abstract available.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.

Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program.
Smailova DS, Fabbro E, Ibrayev SE, Brusati L, Semenova YM, Samarova US, Rakhimzhanova FS, Zhussupov SM, Khismetova ZA, Hosseini H. Smailova DS, et al. Prostate Cancer. 2020 Jan 27;2020:6140623. doi: 10.1155/2020/6140623. eCollection 2020. Prostate Cancer. 2020. PMID: 32411478 Free PMC article.